Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
2 More presentations in this session
Doctor I. Nardi Agmon (Ramat Gan, IL)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
